- Nachrichtendetail
-
26.06.2024 08:00:03 - dpa-AFX: Merck : USDA Approves NOBIVAC NXT, First RNA-Particle Vaccine For Canine Flu H3N2
KENILWORTH (NJ) (dpa-AFX) - Merck Animal Health, a division of Merck & Co.,
Inc., (MRK), announced the U.S. Department of Agriculture or USDA approval of
NOBIVAC NXT Canine Flu H3N2, a next-level solution to help safeguard dogs
against the ongoing threat of canine influenza.
The product is expected to be available at veterinary clinics and hospitals
nationwide late this summer.
Canine influenza, or dog flu, is a serious respiratory illness that is easily
transmitted from dog to dog.
For More Such Health News, visit rttnews.com.
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Inc., (MRK), announced the U.S. Department of Agriculture or USDA approval of
NOBIVAC NXT Canine Flu H3N2, a next-level solution to help safeguard dogs
against the ongoing threat of canine influenza.
The product is expected to be available at veterinary clinics and hospitals
nationwide late this summer.
Canine influenza, or dog flu, is a serious respiratory illness that is easily
transmitted from dog to dog.
For More Such Health News, visit rttnews.com.
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
MERCK CO. DL-,01 | A0YD8Q | Frankfurt | 93,100 | 04.11.24 17:57:21 | -1,300 | -1,38% | 0,000 | 0,000 | 93,500 | 94,400 |
